Medicare Enrolled
Dr. Taral Patel, MD
Medical Oncology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Taral Patel is a medical oncology specialist in Columbus, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 23,339 Medicare services across 1,454 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $745,501 from 105 pharmaceutical and/or device companies across 1368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in OH
$745,501 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,339
Medicare services
Top 14% in OH for medical oncology
1,454
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,167 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
7,415 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 4,680 | $18 | $64 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,780 | $6 | $25 |
| Iron infusion (Monoferric) | 2,400 | $16 | $74 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,386 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
791 | $8 | $29 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
479 | $10 | $67 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
412 | $92 | $390 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
253 | $1 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
235 | $61 | $277 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
213 | $8 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
204 | $94 | $421 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
123 | $1 | $4 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
117 | $21 | $103 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
111 | $11 | $66 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
109 | $69 | $210 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
79 | $46 | $208 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
72 | $47 | $368 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
64 | $50 | $234 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
52 | $149 | $733 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
46 | $15 | $65 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $119 | $509 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
42 | $42 | $180 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
36 | $769 | $4,447 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
36 | $5 | $16 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
21 | $39 | $269 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
21 | $61 | $214 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
19 | $70 | $334 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | $85 | $1,533 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
17 | $4 | $12 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $133 | $550 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
12 | $16 | $72 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
12 | $26 | $86 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $119 | $595 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $100 | $406 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.2% high complexity
79.2% medium
8.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$745,501
Total received (2018-2024)
Avg $106,500/year across 7 years
Top 1% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
105
Companies
1,368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$420,361 (56.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$267,762 (35.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$57,378 (7.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$145,241
2023
$182,450
2022
$169,945
2021
$68,777
2020
$83,450
2019
$73,841
2018
$21,798
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Karyopharm Therapeutics Inc.
$38,330
Janssen Biotech, Inc.
$22,060
Pharmacosmos Therapeutics Inc.
$17,647
GlaxoSmithKline, LLC.
$11,453
Incyte Corporation
$11,407
BeiGene USA, Inc.
$9,685
Gilead Sciences, Inc.
$7,833
E.R. Squibb & Sons, L.L.C.
$7,303
PFIZER INC.
$3,576
AstraZeneca Pharmaceuticals LP
$3,463
Johnson & Johnson Health Care Systems Inc.
$3,058
Mirati Therapeutics, Inc.
$2,130
GENZYME CORPORATION
$1,791
Daiichi Sankyo Inc.
$1,787
Eisai Inc.
$396
Novartis Pharmaceuticals Corporation
$365
Janssen Scientific Affairs, LLC
$355
Fennec Pharmaceuticals, Inc.
$228
Rigel Pharmaceuticals, Inc.
$209
Merck Sharp & Dohme LLC
$187
Genentech USA, Inc.
$178
Blueprint Medicines Corporation
$175
Adaptive Biotechnologies Corporation
$167
Regeneron Healthcare Solutions, Inc.
$146
Stemline Therapeutics Inc.
$122
Exelixis Inc.
$118
SOBI, INC
$108
Astellas Pharma US Inc
$104
JAZZ PHARMACEUTICALS INC.
$95
Celgene Corporation
$75
ABBVIE INC.
$75
EMD Serono, Inc.
$71
ARRAY BIOPHARMA INC
$68
SERVIER PHARMACEUTICALS LLC
$61
Takeda Pharmaceuticals U.S.A., Inc.
$55
SpringWorks Therapeutics, Inc.
$48
Genmab U.S., Inc.
$36
Ipsen Biopharmaceuticals, Inc
$36
Amneal Pharmaceuticals LLC
$36
Geron Corporation
$34
TerSera Therapeutics LLC
$31
Alexion Pharmaceuticals, Inc.
$23
Lilly USA, LLC
$22
Eli Lilly and Company
$21
Amgen Inc.
$20
Aveo Pharmaceuticals, Inc.
$20
Sumitomo Pharma America, Inc.
$17
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 53.7% of 2024 payments
All-time payments by company (2018-2024) ›
Karyopharm Therapeutics Inc.
$134,316
Daiichi Sankyo Inc.
$115,394
Incyte Corporation
$50,467
GlaxoSmithKline, LLC.
$50,077
BeiGene USA, Inc.
$37,489
Janssen Biotech, Inc.
$36,136
EMD Serono, Inc.
$27,411
Takeda Pharmaceuticals U.S.A., Inc.
$22,944
Merck Sharp & Dohme Corporation
$20,118
Pharmacosmos Therapeutics Inc.
$19,174
PFIZER INC.
$17,736
GENZYME CORPORATION
$15,673
Gilead Sciences, Inc.
$15,476
Mirati Therapeutics, Inc.
$14,712
Rigel Pharmaceuticals, Inc.
$14,642
Bayer HealthCare Pharmaceuticals Inc.
$12,199
AstraZeneca Pharmaceuticals LP
$11,389
Apellis Pharmaceuticals, Inc.
$9,895
Verastem, Inc.
$9,463
Astellas Pharma US Inc
$9,153
E.R. Squibb & Sons, L.L.C.
$8,099
Genentech USA, Inc.
$7,791
Puma Biotechnology, Inc.
$6,325
Kite Pharma, Inc.
$6,086
Seattle Genetics, Inc.
$6,042
Epizyme, Inc.,
$5,442
CTI BioPharma Corp.
$5,262
Lilly USA, LLC
$5,152
JAZZ PHARMACEUTICALS INC.
$4,998
Blueprint Medicines Corporation
$4,205
Seagen Inc.
$3,558
Genmab U.S., Inc.
$3,466
Johnson & Johnson Health Care Systems Inc.
$3,403
Janssen Scientific Affairs, LLC
$3,276
Fresenius Kabi USA, LLC
$2,425
Eisai Inc.
$2,266
AMAG Pharmaceuticals, Inc.
$2,104
PFIZER INTERNATIONAL LLC
$2,044
IntrinsiQ Specialty Solutions, Inc.
$1,850
Celgene Corporation
$1,726
Regeneron Healthcare Solutions, Inc.
$1,723
Taiho Oncology, Inc.
$1,418
Adaptive Biotechnologies Corporation
$1,277
Aveo Pharmaceuticals, Inc.
$1,070
Spectrum Pharmaceuticals Inc.
$974
TerSera Therapeutics LLC
$849
Merck Sharp & Dohme LLC
$686
Acceleron Pharma, Inc.
$666
Novartis Pharmaceuticals Corporation
$633
Deciphera Pharmaceuticals Inc.
$540
TG THERAPEUTICS, INC.
$450
Heron Therapeutics, Inc.
$407
Ipsen Biopharmaceuticals, Inc
$357
Exelixis Inc.
$292
SANOFI-AVENTIS U.S. LLC
$269
Alexion Pharmaceuticals, Inc.
$254
Amgen Inc.
$242
ASD Specialty Healthcare, LLC
$233
Fennec Pharmaceuticals, Inc.
$228
Genentech, Inc.
$204
G1 Therapeutics, Inc.
$180
ARRAY BIOPHARMA INC
$173
Pharmacyclics LLC, an AbbVie Company
$164
PharmaEssentia USA Corporation
$153
TESARO, Inc.
$149
Cardinal Health 108, LLC
$149
ASD SPECIALTY HEALTHCARE, LLC
$144
Stemline Therapeutics Inc.
$143
Sirtex Medical Inc
$142
NOVARTIS PHARMACEUTICALS CORPORATION
$139
EISAI INC.
$132
Regeneron Pharmaceuticals, Inc.
$129
SOBI, INC
$125
Myovant Sciences Inc.
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
SERVIER PHARMACEUTICALS LLC
$97
ABBVIE INC.
$93
Coherus Biosciences Inc.
$83
Agios Pharmaceuticals, Inc.
$83
Jazz Pharmaceuticals Inc.
$60
Dendreon Pharmaceuticals LLC
$58
ADC Therapeutics America, Inc.
$58
Amneal Pharmaceuticals LLC
$54
BARD PERIPHERAL VASCULAR, INC.
$49
SpringWorks Therapeutics, Inc.
$48
Sun Pharmaceutical Industries Inc.
$45
Pharmacyclics LLC, An AbbVie Company
$43
Foundation Medicine, Inc.
$41
AVEO Pharmaceuticals, Inc.
$38
AbbVie, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$35
Geron Corporation
$34
Sumitomo Pharma America, Inc.
$31
MorphoSys, US Inc.
$31
Dova Pharmaceuticals
$24
Bard Peripheral Vascular, Inc.
$24
Eli Lilly and Company
$21
TAIHO ONCOLOGY, INC.
$17
Acrotech Biopharma LLC
$17
TOLMAR Pharmaceuticals, Inc.
$15
ImmunoGen, Inc.
$15
Secura Bio, Inc.
$15
Aurobindo Pharma USA, Inc.
$12
PUMA BIOTECHNOLOGY, INC.
$12
Clovis Oncology, Inc.
$9
Top 3 companies account for 40.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · ASPARLAS · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CD38 · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · EMEND · EMPAVELI · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Elahere · Empaveli · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · HEMADY · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Nexavar · Nubeqa · OGSIVEO · OJJAARA · ONIVYDE · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROCRIT · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · QINLOCK · QUZYTTIR · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYTELO · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SYNAGIS · Soliris · Stimufend · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYNDAMAX · VYXEOS · Venclexta · Vonjo · Voranigo · Vyloy · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · ZIRABEV · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for medical oncology in OH.
Geographic Context
Medical oncologists within 10 mi
70
Per 100K population
5.3
County median income
$73,795
Nearest hospital
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 14% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Patel performed 7,415 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $745,501 from 105 companies across 1,368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other medical oncologists in Columbus?
Dr. Patel's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Columbus
Browse medical oncologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology